about
Kodiak Sciences Inc has developed a new technology platform, the Antibody Biopolymer Conjugate (ABC) platform, for retinal medicines. Its investigational medicine, tarcocimab tedromer (Zenkuda or tarcocimab), is an anti-VEGF therapy built on Kodiak's...
Read More
32.64
-0.07
(-0.21%)
438.4K
XNAS Volume
XNAS 21 Sep, 2026 3:33 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Kodiak Sciences Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..